Human leukocyte immunoglobulin-like receptors in health and disease

被引:14
|
作者
Redondo-Garcia, Silvia [1 ]
Barritt, Christopher [1 ,2 ,3 ]
Papagregoriou, Charys [1 ,6 ]
Yeboah, Muchaala [1 ]
Frendeus, Bjorn [1 ,4 ]
Cragg, Mark S. [1 ,5 ]
Roghanian, Ali [1 ,5 ]
机构
[1] Univ Southampton, Sch Canc Sci, Antibody & Vaccine Grp, Ctr Canc Immunol,Fac Med,Southampton Gen Hosp, Southampton, England
[2] Glasgow Royal Infirm, Lister Dept Gen Surg, Glasgow, Scotland
[3] Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Scotland
[4] BioInvent Int AB, Lund, Sweden
[5] Univ Southampton, Inst Life Sci, Southampton, England
[6] Ctr Study Haematol & Other Malignancies, Nicosia, Cyprus
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
LILR; immune tolerance; cancer; autoimmunity; infection; immunomodulation; immunotherapy; MHC CLASS-I; SOLUBLE HLA-G; T-SUPPRESSOR-CELLS; ANTIGEN-PRESENTING CELLS; TOLEROGENIC ENDOTHELIAL-CELLS; PLASMACYTOID DENDRITIC CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACUTE MYELOID-LEUKEMIA; NATURAL-KILLER-CELLS; VERSUS-HOST-DISEASE;
D O I
10.3389/fimmu.2023.1282874
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human leukocyte immunoglobulin (Ig)-like receptors (LILR) are a family of 11 innate immunomodulatory receptors, primarily expressed on lymphoid and myeloid cells. LILRs are either activating (LILRA) or inhibitory (LILRB) depending on their associated signalling domains (D). With the exception of the soluble LILRA3, LILRAs mediate immune activation, while LILRB1-5 primarily inhibit immune responses and mediate tolerance. Abnormal expression and function of LILRs is associated with a range of pathologies, including immune insufficiency (infection and malignancy) and overt immune responses (autoimmunity and alloresponses), suggesting LILRs may be excellent candidates for targeted immunotherapies. This review will discuss the biology and clinical relevance of this extensive family of immune receptors and will summarise the recent developments in targeting LILRs in disease settings, such as cancer, with an update on the clinical trials investigating the therapeutic targeting of these receptors.
引用
收藏
页数:29
相关论文
共 50 条
  • [31] Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis
    Hanson, Aimee L.
    Vukcevic, Damjan
    Leslie, Stephen
    Harris, Jessica
    Cao, Kim-Anh Le
    Kenna, Tony J.
    Brown, Matthew A.
    PLOS GENETICS, 2020, 16 (08):
  • [32] The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium
    Tedla, N
    Gibson, K
    McNeil, HP
    Cosman, D
    Borges, L
    Arm, JP
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (02): : 425 - 431
  • [33] Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations
    Hirayasu, Kouyuki
    Arase, Hisashi
    JOURNAL OF HUMAN GENETICS, 2015, 60 (11) : 703 - 708
  • [34] Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations
    Kouyuki Hirayasu
    Hisashi Arase
    Journal of Human Genetics, 2015, 60 : 703 - 708
  • [35] KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTORS/HUMAN LEUKOCYTE ANTIGEN GENOTYPES CONFER SUSCEPTIBILITY AND PROGRESSION IN PATIENTS WITH AUTOIMMUNE HEPATITIS
    Umemura, Takeji
    Joshita, Satoru
    Yamashita, Yuki
    Yoshizawa, Kaname
    Norman, Gary L.
    Tanaka, Eiji
    Ota, Masao
    HEPATOLOGY, 2019, 70 : 871A - 871A
  • [36] Human leukocyte antigen and killer-cell immunoglobulin-like receptors association with type 1 diabetes mellitus in the Azores
    Pinheiro, J. P.
    Couto, A. R.
    Santos, M. R.
    Fialho, R. N.
    Torres, A.
    Burges-Armas, J.
    TISSUE ANTIGENS, 2008, 71 (04): : 343 - 344
  • [37] Killer-cell immunoglobulin-like receptors
    Parham, P
    FEBS JOURNAL, 2005, 272 : 286 - 286
  • [38] Immunogenetics of killer cell immunoglobulin-like receptors
    Parham, P
    MOLECULAR IMMUNOLOGY, 2005, 42 (04) : 459 - 462
  • [39] Killer Immunoglobulin-like Receptors and Tumor Immunity
    Benson, Don M., Jr.
    Caligiuri, Michael A.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) : 99 - 104
  • [40] The Role of Leukocyte Immunoglobulin-Like Receptors Focusing on the Therapeutic Implications of the Subfamily B2
    Hu, Yanyu
    Lu, Xin
    Qiu, Weimin
    Liu, Hui
    Wang, Qinghua
    Chen, Yao
    Liu, Wenyuan
    Feng, Feng
    Sun, Haopeng
    CURRENT DRUG TARGETS, 2022, 23 (15) : 1430 - 1452